loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 18395 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Dr. Reddy's Laboratories (1)

    filter

    01 CETIRIZINE DIHYDROCHLORIDE (1)

    filter

    01 India (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    DR REDDYS LABORATORIES LTD

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CETIRIZINE DIHYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF RU
    18395
    Active
    2005-05-27
    Complete
    2014-06-16
    2014-06-06
    II
    Dr Reddy Company Banner

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 18395 of Dr Reddys Laboratories Ltd

    Looking for Drug Master Files (DMF) for 18395 of Dr Reddys Laboratories Ltd 1

    20

    Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    One of their notable products is CETIRIZINE DIHYDROCHLORIDE, with a corresponding US DMF Number 18395.

    Remarkably, this DMF maintains an Active status since its submission on May 27, 2005, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2014, and payment made on June 06, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY